Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer
2025 · New England Journal of Medicine · 91 citations
https://doi.org/10.1056/nejmoa2405008
K
Kazumi Nishino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
328
Papers
4.1K
Citations
35
h-index
88
i10-index
Kazumi Nishino is an academic researcher from Osaka International Cancer Institute. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & Lung Cancer Research Studies. The author has an h-index of 35, co-authored 279 publications.
ORCID: 0000-0003-2000-7472Papers by this author
worksGumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial
2023 · EClinicalMedicine · 48 citations
https://doi.org/10.1016/j.eclinm.2023.101952
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
2021 · JTO Clinical and Research Reports · 26 citations
https://doi.org/10.1016/j.jtocrr.2021.100235
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
2016 · Scientific Reports · 17 citations
https://doi.org/10.1038/srep29093
Transient appearance of circulating tumor DNA associated with de novo treatment
2016 · Scientific Reports · 13 citations
https://doi.org/10.1038/srep38639
Infectious pericarditis caused by Gemella sanguinis induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case report
2020 · Respiratory Medicine Case Reports · 11 citations
https://doi.org/10.1016/j.rmcr.2020.101057
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat